Future research should investigate correlations between OPG and other markers of cardiovascular mortality, such as the coronary artery calcium score, and explore whether therapies aimed at reducing the high circulating concentration of OPG in patients with CKD may reduce the high cardiovascular mortality in this patient population. This evidence concerns the gene TNFRSF11B and chronic kidney disease.